AZD1208 treatment of MPN cells frequently led to an increase in PIM1, PIM2, and PIM3 protein (Supplementary Fig. 2A and not shown), suggesting on target inhibition and subsequent stabilization of the protein, as previously reported [54, 59]. The gene discussed is PIM2; the disease is myeloproliferative disorder.